1: Simon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Clayton AH. Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. Obstet Gynecol. 2019 Nov;134(5):909-917. doi: 10.1097/AOG.0000000000003514. 2: Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 2019 Nov;134(5):899-908. doi: 10.1097/AOG.0000000000003500. 3: Dhillon S, Keam SJ. Bremelanotide: First Approval. Drugs. 2019 Sep;79(14):1599-1606. doi: 10.1007/s40265-019-01187-w. Review. Review. Available from http://www.ncbi.nlm.nih.gov/books/NBK544629/ doi: 10.1016/j.jsxm.2019.05.012. Epub 2019 Jul 2. doi: 10.1080/14656566.2019.1582644. Epub 2019 Feb 26. doi: 10.1080/14728214.2018.1527901. Epub 2018 Oct 11. Review. doi: 10.1097/AOG.0000000000002733. doi: 10.1016/j.sxmr.2018.01.003. Epub 2018 Mar 22. Review. doi: 10.1016/j.esxm.2018.01.004. Epub 2018 Mar 6. Review.